Initial Pharmacokinetics and Bioavailability of PSC 833, a P-Glycoprotein Antagonist
- 1 February 1997
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 37 (2) , 123-128
- https://doi.org/10.1002/j.1552-4604.1997.tb04770.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pHCancer Chemotherapy and Pharmacology, 1994
- Pharmacologic interactions between the resistance‐modifying cyclosporine sdz psc 833 and etoposide (VP 16–213) enhance In Vivo cytostatic activity and toxicityInternational Journal of Cancer, 1992
- SDZ PSC 833, A non‐immunosuppressive cyclosporine: Its potency in overcoming P‐glycoprotein‐mediated multidrug resistance of murine leukemiaInternational Journal of Cancer, 1992
- Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumorCancer Chemotherapy and Pharmacology, 1992
- Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.Proceedings of the National Academy of Sciences, 1987
- Expression of a multidrug-resistance gene in human tumors and tissues.Proceedings of the National Academy of Sciences, 1987
- Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteinsCell, 1986
- Isolation and genetic characterization of human KB cell lines resistant to multiple drugsSomatic Cell and Molecular Genetics, 1985
- Reduced permeability in CHO cells as a mechanism of resistance to colchicineJournal of Cellular Physiology, 1974